As of Sep 23
| +0.10 / +2.79%|
The 5 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 3.00. The median estimate represents a +90.22% increase from the last price of 3.68.
The current consensus among 6 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.